News | Cardiovascular Business | December 14, 2022

Corindus, A Siemens Healthineers Company, Is Now Siemens Healthineers Endovascular Robotics

Corindus, A Siemens Healthineers Company, has officially rebranded as Siemens Healthineers

Corindus, A Siemens Healthineers Company, has officially rebranded as Siemens Healthineers

December 14, 2022 — Corindus, A Siemens Healthineers Company, has been rebranded to Siemens Healthineers Endovascular Robotics, a dedicated business within the Advanced Therapies area of Siemens Healthineers. This brand unification is the final step of the company integration process that commenced in 2019 with the acquisition of Corindus by Siemens Healthineers. The aim of the Endovascular Robotics business is to advance interventions with robotics and change the way that care is delivered through innovations that enhance physician technique and bring precision to interventional procedures.

As the dedicated Endovascular Robotics business of Siemens Healthineers, we have access to the resources of a leading global medical technology company, allowing us to continue to advance our vision of developing innovative, image-guided robotic solutions. Siemens Healthineers Endovascular Robotics will continue to offer the CorPath GRX System to support endovascular procedures while working to revolutionize treatment of emergent conditions by developing technologies to provide specialized and timely medical care to more patients around the world.

This transition is actively underway, and all Corindus channels, including the company website and social media profiles, will officially shut down on December 16, 2022. All the materials previously shared via the Corindus website can now be accessed on the Siemens Healthineers website in the Endovascular Robotics section at https://www.siemens-healthineers.com/endovascular-robotics.

Wayne Markowitz, Worldwide Executive Vice President of Siemens Healthineers and Head of Endovascular Robotics, said, “The completion of our brand evolution marks the final step to becoming a united company and we remain focused on pioneering breakthroughs for everyone, everywhere. Our flagship product, the CorPath GRX System, is designed to support endovascular interventions, and we look forward to working with our customers as Siemens Healthineers Endovascular Robotics while fueling our vision to connect more patients to advanced care.”

For more information: https://www.siemens-healthineers.com/endovascular-robotics


Related Content

Feature | Cardiovascular Business

May 24, 2023 — Park Ridge, N.J.-based publisher Wainscot Media has named Laura Dowden as managing director, group ...

Home May 24, 2023
Home
News | Cardiovascular Business

May 3, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that ...

Home May 03, 2023
Home
News | Cardiovascular Business

May 2, 2023 — Auburn Community Hospital (ACH) announced today that Dr. Ronald L. Kirshner has been appointed Chair and ...

Home May 02, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As we head into Spring, let's take a look at the Top 10 topics that viewers were reading about during the month of April ...

Home May 01, 2023
Home
Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD

The European interventional cardiology device market is one of the larger markets in the global space. The market is ...

Home April 24, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

In the blink of an eye yet another month has passed, and here is a look at the Top 10 of what DIcardiology.com viewers ...

Home April 03, 2023
Home
News | Cardiovascular Business

March 29, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home March 29, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 01, 2023
Home
News | Cardiovascular Business

February 17, 2023 — Internationally recognized cardiologist in heart transplantation Jon Kobashigawa, MD, director of ...

Home February 17, 2023
Home
News | Cardiovascular Business

February 9, 2023 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long ...

Home February 09, 2023
Home
Subscribe Now